Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10977023 | 0.94 | TSHR (0.37) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL435016 | 0.90 | TSHR (0.33) | TSHRALDH1A1ZDHHC7 | |
| SCHEMBL23084724 | 0.85 | ALDH1A1 (0.47) | TSHRALDH1A1ZDHHC7 | |
| SCHEMBL3683189 | 0.80 | NAAA (0.38) | TSHRALDH1A1 | |
| SCHEMBL3678777 | 0.80 | ALDH1A1 (0.37) | TSHRALDH1A1ZDHHC7 | |
| SCHEMBL863124 | 0.80 | TSHR (0.43) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL19972984 | 0.79 | TSHR (0.39) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL3128512 | 0.79 | ZDHHC7 (0.42) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL3020917 | 0.78 | TSHR (0.42) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL214602 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050217-A | Method for preparing polymer with controllable dispersity by supermolecule induced switchable chain transfer reagent | 吉林大学 | 2023-11-14 | — | — | CN | disclosed |
| US-9982070-B2 | Aqueous ATRP in the presence of an activator regenerator | CARNEGIE MELLON UNIVERSITY (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170253685-A1 | BLOCK COPOLYMERS THAT CAN BE USED AS PLASTICISERS | STARCIN HOLDING FRANCE (FR) | 2017-09-07 | — | — | US | disclosed |
| US-20160200840-A1 | AQUEOUS ATRP IN THE PRESENCE OF AN ACTIVATOR REGENERATOR | CARNEGIE MELLON UNIVERSITY | 2016-07-14 | — | — | US | disclosed |
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CARESTREAM HEALTH, INC. | 2008-04-24 | — | — | US | disclosed |
| US-RE33745-E | Thiadiazabicyclononane derivatives, processes for their production and herbicidal compositions | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-11-19 | — | — | US | disclosed |
| EP-0238711-B1 | THIADIAZABICYCLONONANE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND HERBIZIDAL COMPOSITIONS | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1990-11-28 | — | — | EP | disclosed |
| US-4816063-A | PLANT GROWTH REGULATORS | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-03-28 | — | — | US | disclosed |
| EP-0238711-A1 | Thiadiazabicyclononane derivatives, processes for their production and herbizidal compositions | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1987-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080095699-A1 | IMAGING CONTRAST AGENTS USING NANOPARTICLES | CD47, MSN, CLTA | TSHR 2213/4885CA12 170/4885CA1 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.